Home
BLISSGVS.NS

Bliss GVS Pharma Limited

NSEHealthcare
₹504.50
-4.29%-₹22.60 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹527.10
Day range
₹0 – ₹0
52W range
₹118 – ₹553
Volume
6.3L
Avg vol (20D)
12.6L
Mkt cap
₹5,352.39Cr
P/E TTM
42.1×

Trade Bliss GVS Pharma Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹927.11 Cr
Net Income (ttm)₹0.00
Shares Out10.61 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta1.13

About BLISSGVS.NS

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1.03 K
Stock ExchangeNSE
Ticker SymbolBLISSGVS.NS
BLISSGVS.NS · NSE
Financial Performance

In 2026, Bliss GVS Pharma Limited's revenue was ₹927.11 Cr, an increase of +29.80% compared to the previous year. Earnings were ₹0.00, an increase of +124.60%.

Revenue (2026)
₹927.11 Cr
+29.80% YoY
Earnings (2026)
₹0.00
+124.60% YoY
Year-over-Year Growth
Revenue
+29.80%
Earnings
+124.60%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.